documents: FDA-2011-P-0416-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-P-0416-0003 FDA FDA-2011-P-0416 Determinations that Product was Not Withdrawn from Sale for Reasons of Safety or Effectiveness: TRAVATAN (Travoprost Ophthalmic Solution), 0.004 percent Notice General Notice 2011-11-16T05:00:00Z 2011 11 2011-11-16T05:00:00Z   2011-11-16T22:11:54Z 2011-29484 0 0 0900006480f6d68f

Links from other tables